Month: February 2026

Atlanta, GA, Feb. 02, 2026 (GLOBE NEWSWIRE) — Trust Stamp, a global provider of AI-powered trust, identity and security solutions provided an overview of business progress for January 2026. Gareth N. Genner, Chief Executive Officer of Trust Stamp reported: “In Q4 of 2025 we completed a financing round using a combination of market placements of stock using our S3 capacity and a warrant inducement agreement. The objective of the financing was to provide working capital to give us the ability to achieve significant growth in 2026, which we intend to do through acquisitions, expansion of our customer base, and growing our service offerings. During January we agreed to terms as part of non-binding letters of intent for two M&A transactions. In each case, the incoming company is a graduate of the UK National Cybersecurity Center’s...

Dallas, TX, Feb. 02, 2026 (GLOBE NEWSWIRE) — Vivakor, Inc. (OTCPINK: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation service, today announced that it has executed a non-binding Letter of Intent to sell its midstream business and transportation assets of CPE Gathering MidCon, LLC (“CPE Gathering”) to Olenox Industries, Inc. (NASDAQ: OLOX) for approximately $36 million. Vivakor is the owner and operator of the Omega pipeline system, an integrated crude-oil gathering, transportation, terminaling and pipeline connection platform serving the Oklahoma STACK play. The transaction, valued at approximately $36 million, will be paid in a combination of cash, promissory note, common and preferred stock, and is based on $4.56 million in annual EBITDA, pursuant to a take-or-pay...

Roseville, Minnesota, Feb. 02, 2026 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTC: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital infrastructure solutions, announces its FY2026 strategic agenda following a year marked by significant operational and financial achievements. A Breakthrough FY2025: Strengthening the Foundation for Scalable Growth FY2025 was a breakout year for SecureTech. The company executed on several major initiatives that strengthened its balance sheet, accelerated operational capabilities, and positioned the business for scalable, long‑term growth. Key Milestones Achieved in FY2025:Acquired AI UltraProd (AIUP): SecureTech completed the acquisition of AI UltraProd, a rapidly growing AI‑driven industrial...

PARAMUS, NJ, Feb. 02, 2026 (GLOBE NEWSWIRE) — Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announced that shares of the Company’s common stock will start trading today on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “PLYX”. “We are pleased to announce that Polaryx’s common stock will begin trading on the Nasdaq Stock Market today,” said Alex Yang, Polaryx’s Chairman and Chief Executive Officer. “This listing is a notable milestone that opens a new and exciting chapter in our development, and we look forward to the many opportunities that lie ahead as we work to develop therapies for devastating rare orphan lysosomal...

DALLAS, Feb. 02, 2026 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will join the American Burn Association (ABA) to promote practical, life-saving burn prevention strategies for workplaces of all types during this year’s National Burn Awareness Week. In support of this annual event, Spectral AI will host a series of internal activities to engage employees, including inspiring messages from leadership, personal stories from biomedical engineers highlighting the importance of innovation in burn care, and interactive burn education. ABA’s theme this year, “Burn Prevention Where You Live, Work, and Play – Preventing Burns in the Workplace,” highlights...

Subscriber milestone reflects continued execution across retail channels BARTLETT, Tenn., Feb. 02, 2026 (GLOBE NEWSWIRE) — SurgePays, Inc. (NASDAQ: SURG), a wireless and fintech point of sale company connecting subprime and underserved consumers to essential mobile and financial services, today announced that its prepaid wireless brand, LinkUp Mobile, has surpassed 100,000 ongoing active subscriber lines. Surpassing 100,000 subscriber lines represents a meaningful milestone for LinkUp Mobile and reflects continued execution of SurgePays’ channel-driven growth strategy. The Company’s model is built around master distributor partnerships and in-store activations across its national retail network, allowing SurgePays to reach prepaid customers where they already live, work, and shop. LinkUp Mobile operates as a prepaid mobile virtual...

NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) today announced it has named Newmark as the exclusive leasing agent for the next stage in its retail transformation in THE PENN DISTRICT on Manhattan’s new West Side. Vornado has tapped the Newmark retail team overseen by Chairman of Global Retail Mark Masinter, who will work closely with Newmark’s Retail Vice Chairman Karen Bellantoni, Jackie Totolo, Pierce Thompson, and Nick Masinter. The reinvention of Vornado’s retail holdings is a core component of its $2.5 billion revitalization of THE PENN DISTRICT campus. Over the past decade, Vornado has redeveloped more than 5 million square feet of Class A office space, introduced more than 300,000 square feet of inviting public plazas, and led a series of public-private partnerships to enhance the area’s transit...

RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2026 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced that members of its leadership team will participate in several leading ophthalmology and industry conferences. Collaborative Community on Ophthalmic Innovation (CCOI)Topic: Opus Genetics leadership will participate in discussions focused on emerging treatment approaches and clinical insights in retinal disease. Date: February 3-4, 2026 Location: Hong KongAsia-Pacific Academy of Ophthalmology Congress (APAO)Topic: The Company will engage with the global ophthalmology community to discuss advances in gene therapy and...

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by positive results from the Phase 2 LEDA trial The upcoming Phase 3 program will therefore be expected to benefit from earlier and more frequent interactions with the FDA under the Fast Track program, potentially enabling a more efficient development pathway This regulatory decision follows the recent clear guidance from the FDA, in which the Company confirmed its clinical evidence strategy for the planned submission of a Biologic License Application (BLA) in H2 2026 for SLK in hidradenitis suppurativa (HS) The PPP program will be discussed at the upcoming Investor Day webcast, confirmed for February 23, 2026, 8.00 – 9.30 am EST (2:00 – 3.30pm CET),...